Singular Genomics Systems Inc (NAS:OMIC)
$ 19.6 0.18 (0.93%) Market Cap: 49.66 Mil Enterprise Value: -14.14 Mil PE Ratio: 0 PB Ratio: 0.40 GF Score: 33/100

Singular Genomics Systems Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 14, 2022 / 11:00PM GMT
Release Date Price: $85.8
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. Welcome, everyone. I'm Matt Sykes, the Life Science Tools and Diagnostics analyst at Goldman Sachs. And have the pleasure of welcoming Drew Spaventa, the Founder and Chief Executive Officer of Singular Genomics. Drew, thank you very much for being here. I appreciate it. Maybe we can start with you kind of setting the stage for us a little bit. You've begun shipping the G4 instruments, which this quarter, which represents many years of hard work and preparation, which is exciting. So maybe you can reflect upon a few of the key accomplishments and then future goals for Singular as you look out over the course of this year.

Andrew Spaventa
Singular Genomics Systems, Inc. - Founder, CEO, President & Chairperson of the Board

Yes, absolutely. Thanks, and thanks for having me. I think we're 1 of the unique stories where if you look at our seed investment deck about 5 years ago. What we set out to do and put on that first slide is very similar to where we are today,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot